Premium
[P1–277]: CROSSBETA STABLE Aβ OLIGOMERS: DISEASE‐RELEVANT DRUG TARGETS AND VERSATILE REFERENCE STANDARDS IN BIOMARKER ASSAYS IN AD
Author(s) -
Apetri Mihaela,
Tepper Armand W.J.W.,
Hoogveld Emily,
Vis Joost D.J.,
Boer Marco,
Scheefhals Guus A.P.H.
Publication year - 2017
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2017.06.293
Subject(s) - oligomer , neurotoxicity , in vivo , amyloid beta , chemistry , drug discovery , fibril , in vitro , drug , amyloid (mycology) , drug development , alzheimer's disease , biochemistry , biology , pharmacology , toxicity , disease , medicine , pathology , peptide , organic chemistry , inorganic chemistry , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom